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ABSTRACT 
 
Rheumatoid arthritis (RA) and periodontitis (PD) are inflammatory diseases 
characterized by an exacerbated immune-inflammatory reaction that leads to 
destruction of bone and other connective tissues that share numerous 
similarities. Although a significant and independent association between has 
been described, the pathophysiological processes that may explain this 
relationship remain unknown and multiple theories have been proposed. This 
review presents the most important theories currently proposed to explain the 
biological link between RA and PD. 
 
1. INTRODUCTION  
 
The available evidence to date, suggests a significant and independent 
association between rheumatoid arthritis (RA) and periodontitis (PD). Both are 
chronic inflammatory diseases characterized by an exacerbated immune-
inflammatory reaction that leads to destruction of bone and other connective 
tissues that share numerous similarities. Hence, the biological mechanisms 
underpinning such a relationship have been a focus of investigation for many 
years. 1 However, the pathophysiological processes that may explain this 
relationship remain unknown and multiple theories have been proposed. 
 
Given the increasing number of clinical studies suggesting beneficial effects of 
periodontal therapy on RA outcomes, there is a need for more studies aimed 
at understanding the mechanisms that connect these two conditions and to 
help explain why periodontal therapy may be beneficial. This review aims to 
lay out the most important theories proposed to explain the biological link 
between RA and PD. 
 
2. Risk factors 
RA and PD have multiple risk factors in common (Table 1) and it has 
therefore been hypothesized that the epidemiological relationship between the 
two conditions could possibly be explained by the “common risk” hypothesis. 
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 Table 1. Shared risk factors between periodontitis and rheumatoid arthritis 
(RA). Acronyms: PMNL, polymorphonuclear leukocyte; C.T, connective tissue 
PERIODONTITIS RA 
Smoking  
Genetics  
Host-mediated C.T. destruction  
A role for plasma cells in active disease  
PMNL infiltration = substantial  
Oxidative stress = major feature  
Female sex hormones play a role  
Symptoms respond to anti-inflammatory drugs  
 
 
 
2.1 Genetic risk factors 
 
RA and periodontitis have certain common genetic factors impacting upon the 
hosts’ immune response that translate into, for example, higher levels of pro-
inflammatory cytokine production. The human leukocyte antigen, alleles DR4 
(HLA-DR4) epitope is located on the surface of leukocytes and has been 
found to be associated with both RA and periodontitis. 2  
 
In common with several other immune-mediated diseases, numerous studies 
report an association between HLA genes and periodontitis. The most recent 
systematic review reported a protective association with HLA-A2 and B5 and 
an increased susceptibility for periodontal disease with HLA-A9 and B15 
genotypes. 3 Whilst classical twin studies have shown that periodontitis 
exhibits a genetic component, 4 genome wide association studies (GWAS) 
have been unable to identify significant associations with chronic periodontitis. 
5 A recent systematic review of 43 studies concluded that there was no 
evidence for an interaction between any genetic variants (including IL1) and 
the sub-gingival microflora. 6  
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In RA, robust data are available from genetic association studies, suggesting 
HLA SE (shared epitope) alleles as the main candidate gene in anti-
citrullinated protein antibodies (ACPA) positive patients. 7 In addition to these 
alleles, GWAS have revealed another 32 loci associated with RA. 8 There is 
also a clear dissimilarity between genetic risk factors for ACPA-positive and 
ACPA-negative RA, thus more research is required to understand the genetic 
differences between these two groups. 9 
 
There are however currently few studies investigating a genetic link between 
RA and periodontitis 10-12 and no GWAS studies. Therefore, the importance of 
genetic polymorphisms in the link between these two diseases remains 
unknown.  
 
2.2 Smoking 
 
Smoking is a shared modifiable risk factor for both periodontitis and RA, 13 
with recent data demonstrating a 3-fold increased risk of RA in ACPA-positive 
men who smoke (1.8-fold increase for women smokers), although no 
association was found in ACPA-negative patients. 14 This association with 
smoking is not however evident in patients with early rheumatoid arthritis. This 
group of patients exhibit a high prevalence of periodontitis but have a low 
prevalence of smoking (16%) and a young age (mean age 42.2 years old). 15 
In contrast, some scientists have reported a significantly higher risk of 
periodontitis in non-smokers with RA 16 whereas others have found an 
association between RA and periodontitis irrespective of smoking status. 17 18 
  
Therefore, although periodontitis and RA share genetic (HLA-DR4) and 
lifestyle (e.g. smoking) risk factors, as well as similar inflammatory pathways, 
these do not appear to be sufficient to explain the connection between the two 
diseases. 19 20 
 
2.3 Poor oral hygiene 
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Poor oral hygiene has also been proposed as a link between rheumatoid 
arthritis and periodontitis. The hypothesis that RA patients are unable to 
maintain good oral hygiene compared to healthy controls due to impaired 
manual dexterity, is attractive as an explanation for the association between 
the two. Indeed, it is logical that the hand and joint deformities evident in the 
most severe forms of RA, alongside the associated functional limitations, 
predispose to poor levels of plaque removal, and therefore an increased risk 
of periodontitis (Figure 1). However, studies have consistently failed to show a 
difference in plaque control that could explain the association with 
periodontitis. 21-23  
 
Figure 1 Patient with rheumatoid arthritis (RA) holding a toothbrush, showing the 
typical hand deformities of severe RA sufferers. 
 
2.4 Gender 
One of the biggest disparities we find between the incidence of RA and 
periodontitis is the gender frequencies. While 75% of RA patients are female, 
men are believed to have worse periodontal health. 24  
 
This gender difference has not been fully investigated although it may well be 
explained by a stronger effect of smoking and obesity in the development of 
periodontitis. However, it is known that in both diseases female hormones 
5 | P a g e  
  
play a role, worsening periodontal status in female puberty, pregnancy and at 
the postmenopausal stage. 25 
 
3. Protein citrullination 
Protein citrullination or “deimination” has been widely studied due to its role in 
autoimmune diseases especially in RA. This post-translational modification of 
proteins occurs when a family of enzymes called peptidyl-arginine deiminase 
(PAD) transforms the amino acid arginine into citrulline. In the presence of 
calcium, PAD replaces the ketamine group (=NH) with a ketone group (=O), 
converting the positively charged arginine into a neutrally charged citrulline 
amino acid. 26 This renders the parent protein hydrophobic, resulting in a 
change in protein folding and thus function (Figure 2). 
 
While citrullination is a physiological phenomenon in healthy individuals, in RA 
citrullinated proteins are recognized as an antigen and activate the immune 
system. 42 Therefore, why the immune system produces antibodies against 
citrullinated proteins in RA patients remains unknown and this unique 
production of auto-antibodies in RA suggests the necessity for an external 
factor to trigger this auto-immune reaction. It has also been shown that PAD 
(in particular PAD-2 and PAD-4) are expressed in inflamed periodontal tissues 
and this may be one important source of protein citrullination, arising many 
years before the RA develops. 27 This event could break the immune 
tolerance to citrullinated proteins and predispose to RA following a second 
insult in the joints themselves. 
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Figure 2. Protein citrullination by Peptidyl-Arginine Deiminase (PAD). In the presence of calcium, PAD catalyses the 
conversion of Arginine in to Citrulline, changing the Ketamine group (=NH) for a Ketone group (=O). 
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3.1. Porphyromonas gingivalis citrullination 
 
Porphyromonas gingivalis (P. gingivalis) is Gram-negative anaerobic bacteria 
strongly associated with periodontitis which is considered key to disruption of 
the host-microbial homeostasis that characterizes the disease. 28 29 30 
Interestingly, P. gingivalis uniquely expresses peptidyl arginine deiminase 
(PPAD) which is capable of citrullinating both host and bacterial peptides 31 
for its survival within the periodontal pocket. 32 It has been observed in some 
in vitro studies that PPAD can only citrullinate C-terminal arginine and not 
internal arginine, in contrast to its homologues human PAD2 and PAD4, 
creating citrullinated peptides that would not normally occur in the absence of 
P. gingivalis. By presenting these neoepitopes to the immune system, P. 
gingivalis  could break immune tolerance to citrullinated proteins and lead to 
the subsequent generation of ACPAs characteristic of RA patients (Figure 3).  
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Figure 3. Model of the biological link between rheumatoid arthritis and 
periodontitis. P. gingivalis breaking immune tolerance to citrullinated proteins in 
rheumatoid arthritis (RA) by bacterial citrullination of proteins through PPAD, 
initiating an immune response leading to loss of tolerance to citrullinated proteins 
in the joints. Abbreviations: P.gingivalis, Porphyromonas gingivalis; PPAD, 
peptidyl arginine deiminase from P.gingivalis; APC, antigen presenting cell; TNF, 
tumour necrosis factor; IL, interleukin; GMCSF, granulocyte-macrophage colony-
stimulating factor.  
9 | P a g e  
  
The potential role of P. gingivalis in the etiology of RA has been investigated 
over the last decade. 33 Martinez-martinez et al 34 found DNA from P.gingivalis 
in the synovial fluid of patients with RA and established that periodontal 
pathogens could be a trigger for the autoimmune response in RA. However, 
PPAD itself to date has not been found within synovial fluid. Hitchon et al. 35 
reported an association between immune responses to P. gingivalis and the 
presence of ACPA in a population with a high background prevalence of the 
RA predisposing HLA alleles. A study by Mikuls et al., showed that high levels 
of anti-P.gingivalis antibodies in RA subjects correlated with levels of ACPAs, 
suggesting that this organism plays a role as a risk factor in RA. 36  
 
Interestingly, it has been observed that the periodontium of periodontitis 
patients with no signs of RA express citrullinated proteins 37 and that serum 
from these patients contain higher levels of antibodies to citrullinated and non-
citrullinated human peptides compared to healthy controls. 38 De Pablo et al. 
suggested that the greater citrullination arising in periodontitis leads to a loss 
of tolerance to citrullinated and un-citrullinated peptides, which may evolve in 
a cross-reaction against the citrullinated proteins in the joint that may in turn 
lead to RA. 
 
Based on these findings, researchers propose that bacterial and human PADs 
could be a therapeutic target in RA. 39 Moreover, it has been hypothesized 
that periodontal therapy could decrease the load of P.gingivalis and PPAD in 
the periodontal pocket and that by reducing gingival inflammation, the 
expression of human PADs could be reduced weakening the autoimmune 
response in RA.   
 
However, it remains unclear whether there is a causal role for antibodies to 
citrullinated proteins in the evolution of RA, and there is no strong evidence 
that periodontal therapy reduces citrullination systemically yet.  
 
3.2.  Other periodontal bacterial candidates to play a role in RA 
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Recently, other periodontal pathogens have been identified as possible 
triggers for RA. In a study conducted by Konig and collaborators, authors 
found that Aggregatibacter actinomycetemcomitans was the only bacteria 
able to induce hypercitrullination within human neutrophils when investigating 
a number of periodontal pathogens and oral commensals. Through secretion 
of leukotoxin A (LtxA), A. actinomycetemcomitans induces calcium influx and 
hyperactivation of PAD in the neutrophil, leading to neutrophil 
hypercitrullination. 40 Interestingly, the effect of human lymphocyte antigen–
DRB1 shared epitope alleles on auto-antibody positivity was limited to RA 
patients who were exposed to A. actinomycetemcomitans.  
 
Last year, a study investigating the oral microbiome in RA, identified 
Cryptobacterium curtum (previously misclassified as Eubacterium saburreum) 
as a predominant member of the RA-influenced periodontal microbiome with a 
100-fold greater abundance in RA and with a 39-fold greater odds of detection 
compared to non-RA controls. 41 Interestingly, this gram-positive anaerobic 
rod/periodontal pathogen 42 degrades arginine through the arginine deiminase 
pathway and produces substantial amounts of citrulline, ornithine and 
ammonia. 43 Others have previously found C. curtum to be enriched in the 
oral and gut microbiomes of early RA cases 15 44 thus the authors suggest that 
C.curtum is a candidate for further studies.  
 
3.3. Citrullinated human proteins targeted in RA  
 
Anti-citrullinated protein antibody (ACPA) testing kits are regularly used by 
rheumatologists to measure antibodies against citrullinated proteins and to 
diagnose patients as ACPA+ and ACPA- which can be used to anticipate 
disease severity and treatment responses. 45 This test uses a synthetic 
citrullinated cyclic peptide as an antigen to capture antibodies against any 
citrullinated proteins present in patient sera. Moreover, investigating the 
proteins that are citrullinated in RA can help us understand the development 
of the autoimmune response and development of the disease. To date, 
numerous studies have reported that proteins including fibrinogen, vimentin, 
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enolase and tenascin are targeted in RA and antibodies against these 
citrullinated proteins are associated with the severity of the disease and also 
elevated in periodontitis patients. 45 46, 47,48 49 47 50 
 
The current data demonstrate that both RA and periodontitis induce 
citrullination, which may be the link between these two diseases. Recently, it 
has been found that the production of citrullinated proteins in the periodontal 
tissues is associated with gingival inflammation, 27 occurring in 80% of 
periodontitis-affected stroma. 37 This is supported by the discovery of higher 
serum antibodies against citrullinated proteins in periodontitis patients 
compared to controls. 38 For this reason, investigators believe that the gingiva 
of periodontitis patients might be an extra-articular source of citrullinated 
proteins, which can lead to ACPA production contributing to RA progression. 
 
3.4. Carbamylation and Malondialdehyde-acetaldehyde adducts 
As detailed above, post-translational modification of proteins can lead to the 
production of autoantibodies and loss of immune tolerance. Apart from 
citrullination, several other post-translational modifications of proteins have 
been associated with RA.  Of these, malondialdehyde-acetaldehyde adducts 
and carbamylated proteins are receiving particular attention. 51 A recent study 
identified immunohistochemical evidence of the presence of 
malondialdehyde-acetaldehyde adducts, citrullinated and carbamylated 
proteins in inflamed human gingival tissue biopsies but not in biopsies of 
healthy, non-inflamed gingivae. 52 Identification of such modified proteins in 
inflamed gingiva suggests that inflammation of the periodontal tissues may 
influence the development of RA. 
 
3.5.  Porphyromonas gingivalis antigens targeted in RA 
 
Proteins from P.gingivalis may be recognized as an antigen by the host and 
initiate an immune response that could break tolerance to human antigens 
such as citrullinated proteins. Based on this hypothesis, researchers have 
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investigated antibodies against some P.gingivalis -antigens and their role in 
RA.   
 
Antibodies against citrullinated PPAD (CPP3 and CPP5) are increased in 
ACPA+ RA patients as well as in periodontitis patients (CPP5). 53 In RA, and 
in patients in the pre-clinical period of the disease (pre-RA patients), anti-
CPP3 antibodies are elevated, 54 although other researchers have been 
unable to find an association between anti-PPAD antibodies and early RA. 55 
Another limitation of this hypothesis is the lack of studies investigating the 
presence of PPAD in inflamed periodontal tissues from RA patients. 
 
While only a few studies have investigated these antibodies and more 
research is needed, considering these results, the hypothesis that P.gingivalis 
-antigens may break immune tolerance in RA, requires further investigation 
and if proven, these epitopes could be targeted in novel therapies for RA 
patients. 56  
 
 
4. The role of the oral microbiome in RA 
 
The human microbiome is defined as “the genes carried by the particular 
community of microorganisms that live in and on the human body”. Using 
DNA-based technologies to investigate bacteria has opened a new chapter in 
our understanding of the microbes that live with us, 57 as traditional cultivation 
techniques limited understanding to the minority of organisms that could be 
grown outside the body.  
 
Currently, three microbiome studies have investigated the oral microbiome in 
RA patients. 58 15 Zhang and collaborators reported the sub-gingival, oral and 
gut microbiome to be altered in RA, and certain species such as Lactobacillus 
salivarius and Cryptobacterium curtum were enriched, therefore offering 
potential diagnostic tools. 58 In a study of early RA patients, Scher and 
colleagues noted that some oral bacterial taxa were significantly different in 
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abundance, however overall measures of diversity were no different to 
systemically healthy controls. In a more recent study investigating the 
periodontally healthy oral microbiome in RA found that compared to controls, 
RA patients had a distinct microbiome with a significantly higher percentage of 
anaerobes, including Cryptobacterium curtum. 41 However, the effect of 
periodontal therapy on the oral microbiome remains to be fully investigated 
using next generation sequencing techniques, and the effect in RA patients 
remains unknown.  
 
5. The cytokine imbalance in RA and Periodontitis 
 
In RA, there is an imbalance between the pro/anti-inflammatory host systems 
59, similar to that reported in periodontitis patients 60. Understanding the 
cytokine networks involved in the pathobiology of RA has led to a revolution in 
the therapeutic arsenal available for this disease in the last decade 61 and 
may also represent a key biological link between RA and periodontitis.  
 
To date, several studies have evaluated the effect of TNF inhibitors in 
periodontitis and RA 62 63 64 65 66. Although the authors concluded that anti-
TNF therapy could benefit periodontal status, they suggest that it is difficult to 
predict the collateral harm that may result from targeting cytokines 
therapeutically. 67  
 
Interestingly, periodontal therapy has been shown to reduce serum TNF 
levels in some studies 68 69, whilst other studies failed to find this reduction 70. 
For this reason, it is important to investigate periodontal therapy as a 
potentially safe and non-pharmacological treatment that could reduce 
inflammation in systemic inflammatory conditions such as RA. 71 72 73 
 
6. Neutrophils and neutrophil extracellular traps  
 
Neutrophils are the first leukocyte to arrive at the site of infection and their 
principal functions include immunological surveillance, recognising and 
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phagocytosing microorganisms, and activation of and collaboration with 
humoral immunity. When activated by multiple inflammatory signals, 
neutrophils may release their enzymatic content to the exterior of the cell, 
together with their DNA, forming a web-like structure called a neutrophil 
extracellular trap (NET), whose purpose is to immobilise microbes and 
prevent their spread. Although effective, the release of these contents, along 
with reactive oxygen species (ROS) provokes collateral tissue damage to the 
surrounding tissues, exacerbates the inflammatory response and exposes 
possible autoantigens. 74 75 
 
Elevated NET formation occurs in both RA and periodontitis patients, 76 77 and 
there is a clear correlation between levels of DNA in the joints, serum ACPA 
levels and neutrophil counts, as well as a clear mapping of citrullinated 
proteins to neutrophils within cell pellets prepared from inflamed joints. NET 
release was also reported to be correlated with high ACPA and rheumatoid 
factor (RF) levels. 78  
 
Taken together, these results suggest that, in periodontitis, a chronic 
exposure of gingival tissues to PAD4 and citrullination may result in the 
breakdown of immune tolerance to citrullinated peptides in susceptible 
individuals which could lead or contribute to RA pathogenesis. NET 
generation may therefore not only contribute to periodontitis and RA 
pathogenesis, but also provides a potential causal link between these two 
conditions (Figure 4). 7 
15 | P a g e  
  
 
Figure 4. Hypothesis of the role of NETs in the connection between RA and periodontitis. Abbreviations: NETs, neutrophil 
extracellular traps; PPAD, peptidyl-arginine deiminase from Porphyromonas gingivalis; H3, histone 3. 
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7. The "Two-hit" model of RA pathogenesis 
 
Golub et al. were the first to describe a theory in which the association 
between periodontitis and systemic diseases could be explained by a "two hit" 
model 80. In this theory, a first "hit" arises within the periodontum, initiated by 
an infection that activates a destructive inflammatory cascade in the 
periodontal tissues. In susceptible patients, a second systemic "hit" then 
occurs, characterized by increased serum levels of pro-inflammatory 
cytokines that amplifies the inflammatory cascade, with production of local 
and systemic pro-inflammatory mediators (cytokines and prostaglandins). 
 
A similar "two hit model" was described 6-years later to explain the 
breakdown of immune tolerance to citrullinated proteins in RA patients 
triggered by smoking. 81 Similar to smoking, periodontitis could represent a 
first hit of citrullinated peptide production. In a first extra-articular hit, chronic 
periodontitis could break immune tolerance to citrullinated proteins, due to 
abnormal levels of protein citrullination within periodontal tissues (the 
periodontal citrullinome). Through epitope spreading (a process in which the 
immune response does not remain fixed towards a specific epitope, but 
extends to include other epitopes on the same protein or other proteins in the 
same tissue), this local autoimmune response to citrullinated proteins could 
lead to the production of ACPAs systemically. These ACPAs react against 
citrullinated proteins in the joint since, in joint diseases there is an increase of 
protein citrullination in the synovium. This model describes a primary "hit" of 
ACPA production due to chronic periodontitis followed by a secondary "hit" in 
the joint, that could induce RA. 19 82 (Figure 5)  
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Figure 5. Two hit model proposed to explain the link between periodontitis and RA. Abbreviations: PAD, peptidylarginine 
deiminase; PPAD, peptidylarginine deiminase from Phorphyromonas gingivalis ; Cit-, citrullinated ; CEP enolase 1; REP non-
citrullinated enolase 1; Cparg negative control for anti-CCP; CCP, anti-cyclic citrullinated protein .  
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8. SUMMARY AND CONCLUSIONS  
 
Although promising, the theories described in this paper to link RA and 
periodontitis remain to be proven and studies supporting them have 
limitations. None of the theories described above explain fully why this 
inflammatory response, initiated or exacerbated by periodontitis, would be 
specific to the joint structures in RA, and it remains unproven whether this link 
is coincidental or due to common risk factors.  
 
A causal relationship between RA and periodontitis cannot be established 
with the current evidence, and if proven, the relationship may only exist in a 
subset of RA patients. 
 
Therefore, future research investigating the oral micobiome, inflammatory and 
autoimmune response of pre-RA patients, RA patients and periodontitis 
patients, is required to clarify gaps in knowledge. Depending upon the 
outcomes of such studies, therapies targeting the microbiome/specific 
microorganisms or components of the immune response could help to prevent 
both diseases. 
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